Patents by Inventor Hideya Yuasa

Hideya Yuasa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9757357
    Abstract: It is intended to provide a therapeutic and/or diagnostic agent that can be used in photodynamic therapy (PDT) or photodynamic diagnosis (PDD) capable of utilizing infrared-spectrum light such as near-infrared light (NIR), infrared light, or far-infrared light, which attains a deep body penetration. The present invention provides a photodynamic therapeutic or diagnostic agent or a photodynamic therapeutic or diagnostic kit for cancer or infectious disease, comprising: a particle (e.g., a lanthanide particle) that emits upconversion luminescence by infrared-spectrum light such as near-infrared light having a wavelength of 0.7 ?m to 2.5 ?m; and a photosensitizer (e.g., porphyrin) or a 5-aminolevulinic acid group.
    Type: Grant
    Filed: April 27, 2012
    Date of Patent: September 12, 2017
    Assignees: Tokyo Institute of Technology, SBI Pharmaceuticals Co., Ltd.
    Inventors: Hideya Yuasa, Shun-ichiro Ogura, Kiwamu Takahashi, Katushi Inoue, Tohru Tanaka
  • Publication number: 20150221447
    Abstract: Provided is a light-emitting composition including a light-emitting compound that exhibits afterglow and represented by the following General Formula (1). where Xn represents 1-4 carboxyl groups, dihydroxybornyl groups, or the like, and Y1m represents 0-2 halogen atoms, methoxy groups, or phenyl groups.
    Type: Application
    Filed: August 23, 2013
    Publication date: August 6, 2015
    Inventors: Hideya Yuasa, Hiroyuki Ohtani, Atsushi Shimoyama, Shinichi Kuno
  • Publication number: 20140056817
    Abstract: It is intended to provide a therapeutic and/or diagnostic agent that can be used in photodynamic therapy (PDT) or photodynamic diagnosis (PDD) capable of utilizing infrared-spectrum light such as near-infrared light (NIR), infrared light, or far-infrared light, which attains a deep body penetration. The present invention provides a photodynamic therapeutic or diagnostic agent or a photodynamic therapeutic or diagnostic kit for cancer or infectious disease, comprising: a particle (e.g., a lanthanide particle) that emits upconversion luminescence by infrared-spectrum light such as near-infrared light having a wavelength of 0.7 ?m to 2.5 ?m; and a photosensitizer (e.g., porphyrin) or a 5-aminolevulinic acid group.
    Type: Application
    Filed: April 27, 2012
    Publication date: February 27, 2014
    Applicants: SBI PHARMACEUTICALS CO., LTD., TOKYO INSTITUTE OF TECHNOLOGY
    Inventors: Hideya Yuasa, Shun-ichiro Ogura, Kiwamu Takahashi, Katushi Inoue, Tohru Tanaka